Bartsch, Rupert http://orcid.org/0000-0002-4384-6917
Bergen, Elisabeth
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 3 October 2019
Accepted: 29 October 2019
First Online: 12 November 2019
Conflict of interest
: R. Bartsch declares the following relations: advisory role for Astra-Zeneca, Celgene, Daiichi, Eisai, Eli-Lilly, MSD, Novartis, Pfizer, Roche, Samsung; lecture honoraria from Accord, Astra-Zeneca, BMS, Celgene, Eli-Lilly, Novartis, Pfizer, Roche, Sandoz; research support from Daiichi, Novartis, Roche. E. Bergen declares that she has no competing interests.